Skip to main content
Fig. 4 | BMC Cardiovascular Disorders

Fig. 4

From: Combining genetic proxies of drug targets and time-to-event analyses from longitudinal observational data to identify target patient populations

Fig. 4

Effect of ADRB1 rs7076938 on time to cardiovascular (CV) death/heart transplant from first atrial fibrillation (AF) diagnosis in (a) unmatched and (b) matched participants, and time to AF rehospitalization or CV death/heart transplant in (c) unmatched and (d) matched participants. Individuals with TT genotype showed increased risk of AF rehospitalization of CV death/heart transplant composite outcome compared to individuals with CC/CT genotypes

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us